Pemetrexed in first-line treatment of non-small cell lung cancer - ScienceDirect
Associations between TS, TTF-1, FR-α, FPGS, and Overall Survival in Patients with Advanced Non–Small-Cell Lung Cancer Receiving Pemetrexed Plus Carboplatin or Gemcitabine Plus Carboplatin as First-Line Chemotherapy - Journal of Thoracic Oncology
Thymidylate synthase inhibitors for thoracic tumors
Pemetrexed disodium, a novel antifolate with multiple targets - The Lancet Oncology
Pemetrexed in Advanced NSCLC: A Review of the Clinical Data
Frontiers | Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting? | Oncology
pemetrexed mechanism of action. | Download Scientific Diagram
![PDF] Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e0dc01ccf28fd86f6fb2d9d5d2827f84c904cfcf/2-Figure1-1.png "PDF] Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules | Semantic Scholar")
PDF] Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules | Semantic Scholar
Mechanisms, Management and Prevention of Pemetrexed-Related Toxicity | SpringerLink
Pemetrexed in non-small-cell lung cancer | Lung Cancer Management
PPT - Mode of Action PowerPoint Presentation, free download - ID:3629643
Pemetrexed disodium | Nature Reviews Drug Discovery
Lung-Tumorzym (LT-Zym) plus Pemetrexed (Alimta) deliver combo punch to terminal non–small cell lung cancer (NSCLC) | Herbalzym
Review of a promising new agent—pemetrexed disodium - Paz‐Ares - 2003 - Cancer - Wiley Online Library
Pemetrexed - Wikiwand
Combined chemotherapy with cytotoxic and targeted compounds for the management of human malignant pleural mesothelioma: Trends in Pharmacological Sciences
Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules | British Journal of Cancer
Genetic polymorphism in ATIC is associated with effectiveness and toxicity of pemetrexed in non-small-cell lung cancer | Thorax
pemetrexed mechanism of action. | Download Scientific Diagram
Predictors of chemotherapy efficacy in non-small-cell lung cancer: a challenging landscape - Annals of Oncology
Antimetabolite pemetrexed primes a favorable tumor microenvironment for immune checkpoint blockade therapy | Journal for ImmunoTherapy of Cancer
Correlation of genetic polymorphisms with clinical outcomes in pemetrexed-treated advanced lung adenocarcinoma patients | Pharmacogenomics
Biochemical Pharmacology of Pemetrexed
Figure 2 from Pemetrexed disodium: a novel antifolate clinically active against multiple solid tumors. | Semantic Scholar
![PDF] Thymidylate synthase inhibitors for thoracic tumors | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/47854ab0ea64059cae613852c069305012727f90/7-Figure3-1.png "PDF] Thymidylate synthase inhibitors for thoracic tumors | Semantic Scholar")
PDF] Thymidylate synthase inhibitors for thoracic tumors | Semantic Scholar
High pemetrexed sensitivity of docetaxel-resistant A549 cells is mediated by TP53 status and downregulated thymidylate synthase
